If you wish to contribute, please don't quickly edit these pages, and rather pay a visit to the Timeline Dialogue. Experimental: Dose expansion_sub-population 2_lower dose of niraparib MTDs and/or prospect RP2Ds for elimusertib utilised together with niraparib at a decreased fixed dose. Patients with recurrent or refractory stable tumors. Sufferers https://ceranib-281357.blog-eye.com/26808572/mcu-i11-for-dummies